New Study on Sleep Breathing Disorders in Achondroplasia Published

A new publication dated October 15, 2026 presents findings on sleep-related breathing disorders in pediatric patients with achondroplasia. The study, titled "Evaluation of sleep-related breathing disorders and polysomnography findings in pediatric patients with achondroplasia," appears in the European Journal of Pediatrics. Vosoritide is an approved treatment associated with achondroplasia care. This publication record documents the study's existence and journal placement as reported. No specific findings, results, or conclusions from the study have been provided in this report. The event data does not indicate whether vosoritide was directly studied, referenced, or evaluated within this particular publication. Readers interested in the clinical context of achondroplasia and related respiratory considerations may wish to consult the full publication directly through the journal. For additional background on vosoritide, including its approved regulatory status, readers can refer to the compound overview for further context.